iRhythm Technologies Inc (STU:I25)
€ 79.5 -2 (-2.45%) Market Cap: 2.51 Bil Enterprise Value: 2.71 Bil PE Ratio: 0 PB Ratio: 37.70 GF Score: 68/100

iRhythm Technologies Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2022 / 06:30PM GMT
Release Date Price: €123 (+37.43%)
K. Gong
JPMorgan Chase & Co, Research Division - Associate

Okay. Thanks, everyone, for being here. My name is Allen Gong. I'm from the medical supply and devices team here at JPMorgan. Thanks for joining us today in the afternoon session at the health care conference. I'm really excited to be introducing iRhythm's management team.

Speaking today will be Quentin Blackford, President and CEO. And joining us on the Q&A will be Doug Devine, CFO and COO; and Dan Wilson, Head of Strategy. If you have any questions that you want me to touch on when we get to the Q&A session, please feel free to e-mail them to me, send to me over Bloomberg or use the built-in capabilities on the online portal.

With that, Quentin, take it away.

Quentin S. Blackford
iRhythm Technologies, Inc. - President, CEO & Director

Thanks for having us, Allen. Look, I'm decided to be here presenting for the first time at the JPMorgan Conference as the CEO of iRhythm. Only 100 days (inaudible), but I can say that I sit here with more excitement about the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot